No photo of David Walk
Contact Expert

View Scopus Profile

David Walk

1992 …2022
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 2 Similar Profiles
Amyotrophic Lateral Sclerosis Medicine & Life Sciences
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Medicine & Life Sciences
Diabetic Neuropathies Medicine & Life Sciences
Intravenous Immunoglobulins Medicine & Life Sciences
Neuralgia Medicine & Life Sciences
Nerve Fibers Medicine & Life Sciences
Polyneuropathies Medicine & Life Sciences
Skin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2003 2022

A Pilot Study of Lung Volume Recruitment Combined with E

Walk, D.

THE ALS ASSOCIATION MINNESOTA, ND AND SD

1/1/18 → 12/31/19

Project: Research project

Resistance Training
Muscle Strength
Lung

A Randomized, Double-Blind, Controlled, Parallel Group S

Walk, D.

FLEX PHARMA, INC.

11/16/17 → 7/14/20

Project: Research project

Charcot-Marie-Tooth Disease
Muscle Cramp
Safety
Therapeutics

A Randomized, Double-Blind, Controlled, Parallel-Group S

Walk, D.

FLEX PHARMA, INC.

10/20/17 → 5/14/20

Project: Research project

Muscle Cramp
Motor Neuron Disease
Safety
Therapeutics

A Phase 2 Randomized, Double-Blind, Placebo-Controlled S

Walk, D.

ACCELERON PHARMA INC.

2/1/17 → 1/31/21

Project: Research project

Charcot-Marie-Tooth Disease
Placebos

Safety of Urate Elevation in ALS - Phase II (SURE-ALS2)

Walk, D.

Massachusetts General Hospital

1/31/17 → 9/30/20

Project: Research project

Uric Acid

Research Output 1992 2019

1 Citation (Scopus)

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

on Behalf of the PRIMA Trial Investigators and the PATH Study Group, Mar 2019, In : Journal of the Peripheral Nervous System. 24, 1, p. 48-55 8 p.

Research output: Contribution to journal › Article

Open Access
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Polyneuropathies
Intravenous Immunoglobulins
Safety
Drug-Related Side Effects and Adverse Reactions
1 Citation (Scopus)

Neurochemical correlates of functional decline in amyotrophic lateral sclerosis

Cheong, I., Deelchand, D. K., Eberly, L. E., Marjanska, M., Manousakis, G. E., Guliani, G., Walk, D. & Oz, G., Mar 1 2019, In : Journal of Neurology, Neurosurgery and Psychiatry. 90, 3, p. 294-301 8 p.

Research output: Contribution to journal › Article

Amyotrophic Lateral Sclerosis
Motor Cortex
Upper Extremity
Pons
Disease Progression

Neurophysiologic techniques to investigate small-fiber excitability

Walk, D., Oct 1 2019, In : Muscle and Nerve. 60, 4, p. 345-346 2 p.

Research output: Contribution to journal › Editorial

1 Citation (Scopus)

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study

on behalf of the PATH study group, Mar 2019, In : Journal of the Peripheral Nervous System. 24, 1, p. 72-79 8 p.

Research output: Contribution to journal › Article

Open Access
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Polyneuropathies
Intravenous Immunoglobulins
Random Allocation
Therapeutics

Clinical handbook of neuromuscular medicine

Walk, D., Jan 1 2018, Springer International Publishing. 220 p.

Research output: Book/Report › Book

Neurology
Medicine
Learning